- Robert C. Green, MD, MPH
This free 3 day NIH sponsored conference brings academia, industry, and government together to accelerate access to gene-targeted therapies. G2P’s Dr. Robert Green co-chairs the planning committee and will be one of the speakers opening the conference on June 3 as well as speaking about BabySeq on June 10.
June 3rd will focus on defining:
- Who are the individuals that could benefit from gene-targeted therapies – now and in the future?
- What novel approaches are needed to enable development of gene-targeted therapies for all genetic rare diseases – now and in the future?
- When is the optimal time to identify individuals who could benefit from gene-targeted therapies (e.g., newborn screening)?
June 10th will focus on identifying existing systems that can be leveraged or adapted to bring treatments to the individuals who can benefit from them.
June 17th will focus on identifying gaps that need to be addressed to facilitate the effective dissemination of treatments in an equitable manner.